THE OPHTHALMIC JOURNAL

I have really enjoyed the first few months of this year, with several events and conferences providing opportunities to catch up with old friends and reflect on how fortunate I am to work in such a fantastic industry.

Most recently, I was in Fremantle for Optometry Western Australia’s WAVE conference. If you haven’t been there, you must! Fremantle is a

small, historic town and due to its size, pretty much everyone who attends the conference in person stays onsite. That makes the event both clinically valuable and fun: wherever you go, you bump into someone you know.

The other fantastic event I attended was Women with Vision. While the majority of optometrists these days are women, most practice owners are men. This is changing, of course, but it takes time. Women with Vision was pitched as a festival: a celebration of ideas and achievements, and a ‘safe’ place in which women could share stories. The energy on the day was incredible, and it extended well beyond with ongoing connections, both face-to-face and via social media.

May is Macula Month, Macular Disease Foundation Australia’s (MDFA’s) annual awareness campaign that aims to educate and bring people into your practices to have their vision checked for macular disease. Now in its 25th year, MDFA has made massive inroads into community awareness of, and support for, people living with macular disease. The Foundation has also supported researchers in their efforts to find cures for macular diseases, including neovascular age-related macular degeneration, dry AMD, and its more advanced form, geographic atrophy. But it’s not only AMD that MDFA is focused on. This national organisation supports research into, and patients with, diabetic eye disease, inherited retinal diseases like Stargardt and Best disease, and other macular conditions.

If you haven’t been to the website, visit mdfoundation.com.au to

discover the resources available, and be sure to get behind Macula Month this year. And don’t forget to read this issue of which is loaded with great articles exploring the latest advances in macular disease diagnosis and treatment.

EDITOR

In the spirit of reconciliation, Custodians of country throughout Australia and their connections to land, sea, and community. We pay our respect to their Elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today. As a bi-national publication, we acknowledge Māori as tangata whenua and Treaty of Waitangi partners in Aotearoa New Zealand.

mivision acknowledges the Traditional

Melanie Kell (+61) 2 8336 8619 melanie@mivision.com.auMelanie Kell (+61) 2 8336 8619 melanie@mivision.com.auTodd Tai (+61) 2 8336 8614 todd@mivision.com.auTodd Tai (+61) 2 8336 8614 todd@mivision.com.auJessica Simon (+61) 2 8336 8617 jessica@mivision.com.auJessica Simon (+61) 2 8336 8617 jessica@mivision.com.auNikki Byrne (+61) 2 8336 8616 nikki@mivision.com.auNikki Byrne (+61) 2 8336 8616 nikki@mivision.com.au

mi vision

Maren Carson (+61) 488 219 333 maren@mivision.com.auMaren Carson (+61) 488 219 333 maren@mivision.com.auMichelle Hauschild michelle@mivision.com.auMichelle Hauschild michelle@mivision.com.au

contributors

OPHTHALMOLOGISTS

Professor Robyn Guymer AM is a Deputy Director and the Head of Macular Research at the Centre for Eye Research Australia, and Professor of Ophthalmology at The University of Melbourne. She is a clinician scientist who leads a team of researchers primarily investigating age-related macular degeneration.

OPTOMETRISTS

Inez Hsing is a clinical optometrist with special interests in ocular disease and provision of collaborative care in the areas of retinal/macular disease and glaucoma.

PROFESSION INFLUENCERS

Dr Kathy Chapman is the Chief Executive Officer of Macular Disease Foundation Australia and the guest editor of this issue of mivision . She reviews 25 years of the Foundation’s work supporting and advocating for patients with macular disease and pursuing cures.